MDRNA, Inc. (MRNA) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 1046 transactions totaling $789.8M, demonstrating a bearish sentiment with -$789.8M in net insider flow. The most recent transaction on Dec 11, 2025 involved a transaction of 688,073 shares valued at $7.5M.
No significant insider buying has been recorded for MRNA in the recent period.
No significant insider selling has been recorded for MRNA in the recent period.
Based on recent SEC filings, insider sentiment for MRNA is bearish with an Insider Alignment Score of 0/100 and a net flow of -$789.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at MDRNA, Inc. (MRNA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading MRNA stock, having executed 1046 transactions in the past 90 days. The most active insider is Stephane Bancel (Executive), who has made 569 transactions totaling $616.0M.
Get notified when executives and directors at MRNA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | Bancel Stephane | Executive | Option Exercise | 688,073 | $10.90 | $7.5M | Large |
| Dec 11, 2025 | Afeyan Noubar | Executive | Sale | 23,853 | $29.49 | $703.4K | Large |
| Dec 11, 2025 | Afeyan Noubar | Executive | Option Exercise | 23,853 | $10.90 | $260.0K | |
| Dec 9, 2025 | Hussain Abbas | Executive | Sale | 504 | $27.60 | $13.9K | |
| Dec 5, 2025 | Thyme Klinger Shannon | Executive | Payment | 22,817 | $25.49 | $581.6K | Large |
| Dec 5, 2025 | Thyme Klinger Shannon | Executive | Option Exercise | 47,190 | $N/A | $0 | |
| Dec 5, 2025 | M. Mock James | Executive | Payment | 22,817 | $25.49 | $581.6K | Large |
| Dec 5, 2025 | M. Mock James | Executive | Option Exercise | 47,190 | $N/A | $0 | |
| Dec 1, 2025 | Hoge Stephen | Executive | Payment | 316 | $25.98 | $8.2K | |
| Dec 1, 2025 | Hoge Stephen | Executive | Option Exercise | 652 | $N/A | $0 | |
| Dec 1, 2025 | Thyme Klinger Shannon | Executive | Option Exercise | 233 | $N/A | $0 | |
| Dec 1, 2025 | Thyme Klinger Shannon | Executive | Payment | 113 | $25.98 | $2.9K | |
| Nov 28, 2025 | Hoge Stephen | Executive | Option Exercise | 610 | $N/A | $0 | |
| Nov 28, 2025 | Hoge Stephen | Executive | Payment | 295 | $25.01 | $7.4K | |
| Nov 28, 2025 | Thyme Klinger Shannon | Executive | Payment | 160 | $25.01 | $4.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 811 | $789.8M | 98.3% |
Exercise(M) | 211 | $12.6M | 1.6% |
Payment(F) | 20 | $1.3M | 0.2% |
Other(J) | 2 | $0 | 0.0% |
Award(A) | 2 | $0 | 0.0% |
Insider selling pressure at MDRNA, Inc. has increased, with 14 insiders executing 1046 transactions across all time. Total sales of $789.8M significantly outpace purchases of $0, resulting in a net outflow of $789.8M. This selling activity appears largely discretionary, which may warrant closer attention from investors.